Traws Pharma, Inc. Accumulated Other Comprehensive Income
Traws Pharma, Inc. (TRAW) had Accumulated Other Comprehensive Income of -$5.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $6.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $6.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$5.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$2.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $6.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $9.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$19.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$42.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | -$33.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$33.00K 10-Q · filed 2024-08-15 |
| 2024-03-31 | -$30.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$23.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$30.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$28.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$27.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$33.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$61.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$41.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$21.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$14.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$6.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$2.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $14.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | -$2.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$17.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$24.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$18.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | -$27.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$14.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$18.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$12.00K 10-K · filed 2020-03-27 |
| 2018-09-30 | -$7.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$5.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $11.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $3.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | -$1.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$10.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$26.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$31.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | -$17.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$19.00K 10-Q · filed 2016-08-15 |
| 2016-03-31 | -$16.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | -$22.00K 10-K · filed 2017-03-29 |
| 2015-09-30 | -$18.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$14.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | -$43.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | -$13.00K 10-K · filed 2016-03-28 |
| 2014-09-30 | -$8.00K 10-Q · filed 2014-11-14 |
| 2013-12-31 | $1.00K 10-K · filed 2015-03-30 |
| 2013-09-30 | -$18.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $5.00K 10-Q · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |